Condensed Statement of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Shareholders' deficiency, Beginning balance at Jan. 31, 2014	$ (258,908)	$ 1,233	$ 81,323	$ (213,038)	$ (128,426)
Common stock, shares outstanding, Beginning balance at Jan. 31, 2014	1,233,853	1,233,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(58,603)	0	0	0	(58,603)
Shareholders' deficiency, Ending balance at Oct. 31, 2014	$ (317,511)	$ 1,233	$ 81,323	$ (213,038)	$ (187,029)
Common stock, shares outstanding, Ending balance at Oct. 31, 2014	1,233,853	1,233,853